Selection of antimicrobial agents in bacterial infections of the nervous system.
D000196:Actinomycosis / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001442:Bacteroides Infections / Q000188:drug therapy; D001922:Brain Abscess / Q000188:drug therapy* / Q000209:etiology; D004653:Empyema / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008581:Meningitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D009617:Nocardia Infections / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy; D013355:Subdural Space; D013449:Sulfonamides / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D010406:Penicillins; D013449:Sulfonamides